Close
Achema middle east
swop processing & packaging

Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Syntegon Reports Strong Q3 2025 Growth and Margin Expansion

Syntegon Delivers Strong Growth and Margin Expansion in Q3...

API China – The Pharmaceutical Ingredients Exhibition Concludes

API China, the first and longest-running pharmaceutical ingredients exhibition...

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand...
- Advertisement -

Biogen Idec Inc. announced today that its presentation at the Deutsche Bank 37th Annual Healthcare Conference will be webcast live on Tuesday, May 8, 2012 at 10:00 a.m. ET.

To access the live webcast, please visit Biogen Idec’s Investor Relations section (www.investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

 

 

 

Latest stories

Related stories

Syntegon Reports Strong Q3 2025 Growth and Margin Expansion

Syntegon Delivers Strong Growth and Margin Expansion in Q3...

API China – The Pharmaceutical Ingredients Exhibition Concludes

API China, the first and longest-running pharmaceutical ingredients exhibition...

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »